stars 1 stars 2 stars 3

Seqirus is a transcontinental partner in pandemic preparedness and a major contributor to the prevention of influenza globally, with extensive research and production expertise and manufacturing plants in the US, UK and Australia. We utilise both egg and cell-based technologies for influenza vaccine production and have developed the only adjuvanted seasonal influenza vaccine for elderly populations. Our scientists continue to optimise these innovative technologies whilst working on longer-term transformational approaches to influenza protection. As part of the CSL Group, we have been producing influenza vaccine in Melbourne, Australia since the 1940’s. Our site in Liverpool UK, is a Centre of Excellence for adjuvanted influenza vaccine manufacturing while our state-of-the-art production facility in Holly Springs US, was purpose-built to harness newer cell-based technology.

View Top Employees from Seqirus
Employees 2,051 (2,051 on RocketReach)
Founded 1916
Category Pharmaceutical Manufacturing, Vaccines, Antivenoms, Contract logistics, In-licensing, Immunohaematology, Pharmaceuticals
Web Rank 2 Million
Keywords seqirus, sequiris, csl liverpool, seqirus inc. careers jobs, seqirus inc.

Seqirus Questions

Joaquin Mould is the Global Pricing and Health Economics Director of Seqirus.

2,051 people are employed at Seqirus.

Top Seqirus Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
G2Crowd Trusted
300K+ Plugin Users